Erratum to: Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting

被引：0
|
作者：
Daniel H. Deck
Jennifer M. Jordan
Thomas L. Holland
Weihong Fan
Matthew A. Wikler
Katherine A. Sulham
G. Ralph Corey
机构：
[1] The Medicines Company,
[2] Duke University Hospital,undefined
来源：
Infectious Diseases and Therapy | 2016年 / 5卷 / 3期
关键词：
D O I：
10.1007/s40121-016-0127-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：363 / 365
页数：2
相关论文
共 50 条
  • [1] Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting
    Deck D.H.
    Jordan J.M.
    Holland T.L.
    Fan W.
    Wikler M.A.
    Sulham K.A.
    Ralph Corey G.
    Infectious Diseases and Therapy, 2016, 5 (3) : 353 - 361
  • [2] Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting (vol 5, pg 353, 2016)
    Deck, Daniel H.
    Jordan, Jennifer M.
    Holland, Thomas L.
    Fan, Weihong
    Wikler, Matthew A.
    Sulham, Katherine A.
    Corey, G. Ralph
    INFECTIOUS DISEASES AND THERAPY, 2016, 5 (03) : 363 - 365
  • [3] Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections
    Corey, G. Ralph
    Kabler, Heidi
    Mehra, Purvi
    Gupta, Sandeep
    Overcash, J. Scott
    Porwal, Ashwin
    Giordano, Philip
    Lucasti, Christopher
    Perez, Antonio
    Good, Samantha
    Jiang, Hai
    Moeck, Greg
    O'Riordan, William
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (23): : 2180 - 2190
  • [4] Oritavancin, a single-dose, complete regimen, for the treatment of acute bacterial skin and skin structure infections
    Wu, Gary
    Truong, James
    Lee, Spencer
    Elnadoury, Ola
    Kuan, William
    Abraham, Teena
    Wu, Anh
    Liu, Mei
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (04) : 409 - 416
  • [5] Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infections
    Rappo, Urania
    Gonzalez, Pedro L.
    Puttagunta, Sailaja
    Akinapelli, Karthik
    Keyloun, Katelyn
    Gillard, Patrick
    Liu, Yan
    Dunne, Michael W.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2019, 17 : 60 - 65
  • [6] Review of oritavancin for the treatment of acute bacterial skin and skin structure infections
    Alejandro Garcia-Robles, Ana
    Lopez Briz, Eduardo
    Fraga Fuentes, Maria Dolores
    Asensi Diez, Rocio
    Sierra Sanchez, Jescis Francisco
    FARMACIA HOSPITALARIA, 2018, 42 (02) : 73 - 81
  • [7] Oritavancin for acute bacterial skin and skin structure infections
    Messina, Julia A.
    Fowler, Vance G., Jr.
    Corey, G. Ralph
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (07) : 1091 - 1098
  • [8] Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections
    Garnock-Jones, Karly P.
    DRUGS, 2017, 77 (01) : 75 - 83
  • [9] Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections
    Karly P. Garnock-Jones
    Drugs, 2017, 77 : 75 - 83
  • [10] Single-Dose Oritavancin Versus 7-10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study
    Corey, G. Ralph
    Good, Samantha
    Jiang, Hai
    Moeck, Greg
    Wikler, Matthew
    Green, Sinikka
    Manos, Paul
    Keech, Richard
    Singh, Rajesh
    Heller, Barry
    Bubnova, Natalia
    O'Riordan, William
    CLINICAL INFECTIOUS DISEASES, 2015, 60 (02) : 254 - 262
12345